Tissue plasminogen activator (tPA) in the management of predominantly hemorrhagic age-related macular degeneration, milligram/milliliter or microgram/milliliter?
Clin Ophthalmol
.
2012:6:145.
doi: 10.2147/OPTH.S28071.
Epub 2012 Jan 19.
Authors
Niels Willem Boone
1
,
Roelof Wouter Frederik van Leeuwen
Affiliation
1
Maastricht University Medical Centre, Department of Clinical Pharmacy and Toxicology, Maastricht, The Netherlands.
PMID:
22291455
PMCID:
PMC3267534
DOI:
10.2147/OPTH.S28071
No abstract available